Prostate cancer is a serious health condition that affects thousands of men each year. While the most common symptom of prostate cancer is difficulty urinating, there are many other surprising symptoms that can indicate the presence of the disease. In this article, we will discuss the surprising symptoms of prostate cancer and what doctors need to know about them.
Prostate cancer is a type of cancer that affects the prostate, a small gland located just below the bladder in men. The prostate is responsible for producing semen, the fluid that carries sperm. Prostate cancer occurs when abnormal cells in the prostate grow and divide uncontrollably. The cancer cells can spread to other parts of the body, such as the bones and lymph nodes. It is the second most common type of cancer in men, after skin cancer.
The most common symptom of prostate cancer is difficulty urinating, which is usually caused by an enlarged prostate. Other common symptoms include a weak or interrupted urine stream, frequent urination, and pain or burning during urination. Some men may also experience pain in the lower back, hips, or upper thighs.
While the most common symptoms of prostate cancer are related to urination, there are several other symptoms that may be less obvious. These include:
These symptoms can be caused by other conditions, such as an enlarged prostate or urinary tract infection, but they can also be signs of prostate cancer. It is important for doctors to be aware of these symptoms and to investigate further if they occur.
If a doctor suspects prostate cancer, they will typically order a blood test called a prostate-specific antigen (PSA) test. This test measures the amount of PSA in the blood, which can be elevated in men with prostate cancer. Other tests, such as a biopsy, may also be ordered to confirm the diagnosis. Once prostate cancer is diagnosed, treatment options include surgery, radiation therapy, and hormone therapy. The type of treatment depends on the stage of the cancer and the patient’s overall health and preferences. In some cases, doctors may also recommend active surveillance, which involves closely monitoring the cancer without treatment.
Prostate cancer is a serious health condition that affects thousands of men each year. While the most common symptom of prostate cancer is difficulty urinating, there are many other surprising symptoms that can indicate the presence of the disease. It is important for doctors to be aware of these symptoms and to investigate further if they occur. If prostate cancer is diagnosed, treatment options include surgery, radiation therapy, and hormone therapy. By being aware of the symptoms of prostate cancer, doctors can help ensure that their patients receive the best possible care.
1.
The clinical trial of ENZAMET shows promise as a treatment for prostate cancer.
2.
Lung Cancer Screening Rates in Eligible Adults Remain Low, Uneven
3.
TikTok creators perform 'roles' when sharing their hereditary cancer stories, shaping the health information they share
4.
It Is Not Just the Royals Who Go Through Cancer.
5.
Joe Biden has prostate cancer with bone spread. An oncologist explains what you need to know
1.
Unlocking the Potential of Leukemia Treatment: A New Hope for Patients
2.
Managing KRAS Inhibitor Toxicities: Focus on Rash and Beyond
3.
ERASur: Evaluating Total Ablative Therapy in Limited Metastatic Colorectal Cancer
4.
Oncology Partnerships: Driving Innovation Through Strategic Collaborations and Pharma Engagement USA
5.
Omega-3 Fatty Acids as Molecular Adjuvants Against Chemoresistance in Breast Cancer
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part V
2.
The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management- Further Discussion
3.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part I
4.
Redefining Treatment Pathways in Relapsed/Refractory Adult B-Cell ALL
5.
CDK4/6 Inhibitors in Extending Overall Survival in HR+/HER2- aBC Patients in Clinical Trial and Real World
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation